Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus

Código QR

Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus

Ashutosh Ojha,1 Utkarsh Ojha,2 Raihan Mohammed,3 Abhinaya Chandrashekar,2 Harsh Ojha41Shobhaben Pratapbhai Patel School Of Pharmacy & Technology Management, SVKM’s Narsee Monjee Institute of Management Studies, Mumbai, India; 2Faculty of Medicine, Imperial College London, London, U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ojha A, Ojha U, Mohammed R, Chandrashekar A, Ojha H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Type 2 Diabetes Mellitus Insulin Glucagon Glucose Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/491e87bce1114af5b10272e56519ebe8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
por: Ekaterina Alekseevna Shestakova
Publicado: (2011)

Insulin resistance in pathogenesis of type 2 diabetes mellitus
por: Alexander Yur'evich Mayorov
Publicado: (2011)

Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets
por: Muhan Jing, et al.
Publicado: (2021)

Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM
por: Wang X, et al.
Publicado: (2021)

Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
por: Hua-Xing Huang, et al.
Publicado: (2021)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
por: Gagik R. Galstyan, et al.
Publicado: (2017)

Insulin Regulation of <i>Escherichia coli</i> Abiotic Biofilm Formation: Effect of Nutrients and Growth Conditions
por: Nina Patel, et al.
Publicado: (2021)

Statin on insulin and adiponectin levels: true or false prophecy?
por: Jonnalagadda VG, et al.
Publicado: (2018)

Effects of Metronidazole as an Adjunct to Non-Surgical Periodontal Therapy on Insulin Resistance in Type 2 Diabetics
por: Ambrina Qureshi, et al.
Publicado: (2021)

Vildagliptin: optimal control in type 2 diabetes mellitus treatment
por: Alexander Sergeevich Ametov
Publicado: (2015)

Magnesium upregulates insulin receptor and glucose transporter-4 in streptozotocin-nicotinamide-induced type-2 diabetic rats
por: Morakinyo Ayodele Olufemi, et al.
Publicado: (2018)

Patterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults
por: Tao Yuan, et al.
Publicado: (2021)

The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance
por: William A. Banks, et al.
Publicado: (2021)

The effects of structured self-monitoring of blood glucose on therapeutic effectiveness and adherence in patients with type 2 diabetes mellitus initiating insulin treatment
por: Lyudmila Alexandrovna Suvorova, et al.
Publicado: (2013)

Immunohystochemical study of the largest islets of human pancreas in aging and diabetes mellitus: perspectives for the transplantation
por: Alexandra Evgen'evna Proshchina, et al.
Publicado: (2013)

The associations of incretin hormone concentration with gestational diabetes mellitus
por: Tatiana V. Saprina, et al.
Publicado: (2016)

Mechanisms of cardiovascular protection of non-insulin antidiabetic medications
por: Angelo Avogaro
Publicado: (2018)

Simultaneous Effect of Resveratrol and Probiotics on Insulin Resistance and Glucagon-Like Peptide (GLP-1) Levels in Diabetic Rats
por: A Pegah, et al.
Publicado: (2021)

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
por: Marina V. Shestakova, et al.
Publicado: (2017)

Veratrilla baillonii Franch Ameliorates Diabetic Liver Injury by Alleviating Insulin Resistance in Rats
por: Zhi-Hao Zhang, et al.
Publicado: (2021)

Glucose transporters in kidney; the role of gender and diabetes mellitus
por: Fatemeh Kharazmi, et al.
Publicado: (2022)

Comparison of rechargeable versus battery-operated insulin pumps: temperature fluctuations
por: Vereshchetin P, et al.
Publicado: (2016)

Glucagon and alpha-cells as a novel therapeutic target in the management of diabetes mellitus
por: Nina Alexandrovna Petunina, et al.
Publicado: (2013)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
por: Elena V. Buryukova, et al.
Publicado: (2017)

To Assess Liraglutide’s Therapeutic Effect in Patients with Type 2 Diabetes Mellitus Using Flash Glucose Monitoring System
por: Yin J, et al.
Publicado: (2021)

Predictors of Insulin Treatment During Pregnancy and Abnormal Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus
por: Tang L, et al.
Publicado: (2019)

Evaluation of glycaemic profile variability as a basis for insulin therapy strategy in pregnant women with type 1 diabetes
por: Alena V. Tiselko, et al.
Publicado: (2019)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
por: Irina A. Kurnikova, et al.
Publicado: (2018)

The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
por: Juris J. Meier
Publicado: (2019)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
por: Minara S. Shamkhalova, et al.
Publicado: (2020)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Insulin Resistance Remission Following Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy in Chinese Type 2 Diabetes Mellitus Patients With a Body Mass Index of 27.5–32.5 kg/m2
por: Ping Luo, et al.
Publicado: (2021)

Topical application of Cinnamomum hydroethanolic extract improves wound healing by enhancing re-epithelialization and keratin biosynthesis in streptozotocin-induced diabetic mice
por: Amin Daemi, et al.
Publicado: (2019)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee J, et al.
Publicado: (2019)

Determinación del índice de resistencia insulínica mediante HOMA en una población de la Región Metropolitana de Chile
por: Acosta B,Ana M, et al.
Publicado: (2002)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
por: Olga Yuryevna Sukhareva, et al.
Publicado: (2016)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
por: Nina A. Petunina, et al.
Publicado: (2018)

Diabetes Mellitus tipo 2 con tendencia a la cetosis: Caso clínico
por: Concha L,Luciana, et al.
Publicado: (2015)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2012)